Sobr Safe (SOBR) had the highest return between December 1, 2019 and December 20, 2019 by a US stock, returning 244%.
| ASSET | DATE | % RETURN |
|---|---|---|
Sobr Safe (SOBR) | 12/1/2019 - 12/20/2019 | 243.98% |
Monopar Therapeutics (MNPR) | 12/1/2019 - 12/20/2019 | 223.35% |
Mirum Pharmaceuticals (MIRM) | 12/1/2019 - 12/20/2019 | 222.44% |
Axsome Therapeutics (AXSM) | 12/1/2019 - 12/20/2019 | 149.74% |
Aurinia Pharmaceuticals (AUPH) | 12/1/2019 - 12/20/2019 | 143.56% |
Quince Therapeutics (QNCX) | 12/1/2019 - 12/20/2019 | 143.03% |
iBio, Inc Common Stock (IBIO) | 12/1/2019 - 12/20/2019 | 132.76% |
AYRO (AYRO) | 12/1/2019 - 12/20/2019 | 106.86% |
Neurogene (NGNE) | 12/1/2019 - 12/20/2019 | 94.89% |
Aptose Biosciences (APTO) | 12/1/2019 - 12/20/2019 | 92.25% |
Kodiak Sciences (KOD) | 12/1/2019 - 12/20/2019 | 91.51% |
Cibus Global LLC (CBUS) | 12/1/2019 - 12/20/2019 | 88.53% |
BW LPG (BWLP) | 12/1/2019 - 12/20/2019 | 87.47% |
Immunitybio (IBRX) | 12/1/2019 - 12/20/2019 | 86.93% |
IGM Biosciences (IGMS) | 12/1/2019 - 12/20/2019 | 83.43% |
Shineco (SISI) | 12/1/2019 - 12/20/2019 | 81% |
Arbutus Biopharma (ABUS) | 12/1/2019 - 12/20/2019 | 72.02% |
Barnwell Industries (BRN) | 12/1/2019 - 12/20/2019 | 71.06% |
XBiotech (XBIT) | 12/1/2019 - 12/20/2019 | 70.56% |
GlucoTrack (GCTK) | 12/1/2019 - 12/20/2019 | 70.45% |
Intellinetics (INLX) | 12/1/2019 - 12/20/2019 | 68.44% |
Entero Therapeutics (ENTO) | 12/1/2019 - 12/20/2019 | 66.91% |
VistaGen Therapeutics (VTGN) | 12/1/2019 - 12/20/2019 | 66.55% |
Lexicon Pharmaceuticals (LXRX) | 12/1/2019 - 12/20/2019 | 66.42% |
Clearside Biomedical (CLSD) | 12/1/2019 - 12/20/2019 | 66.23% |
